Morphometric changes in early- and late-life major depressive disorder: Evidence from postmortem studies

International Psychogeriatrics

Volumn 21, Issue 5, 2009, Pages 844-854

  Khundakar, Ahmad A ^a   Thomas, Alan J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Elderly; Glial cells; Major depressive disorder; Morphology; Neurons; Pathology; Vascular

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; DOPAMINE RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTAMIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN;

AGE DISTRIBUTION; AMYGDALOID NUCLEUS; AUTOPSY; BIPOLAR DISORDER; BRAIN CORTEX; BRAIN TISSUE; CELL DENSITY; CELL POPULATION; CELL SHAPE; CELL SIZE; CELL STRUCTURE; CINGULATE GYRUS; CORTICOSTEROID BLOOD LEVEL; DENTATE GYRUS; DEPRESSION; EMOTION; ENTORHINAL CORTEX; FRONTAL CORTEX; GLIA CELL; GLIOSIS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; MAJOR DEPRESSION; MORPHOMETRICS; NERVE CELL; NEUROBIOLOGY; NEUROIMAGING; ORBITAL CORTEX; PREFRONTAL CORTEX; PYRAMIDAL NERVE CELL; REVIEW; THALAMUS; THREE DIMENSIONAL IMAGING; ADULT; AGE; AGED; ARTICLE; CELL COUNT; FRONTAL LOBE; GLIA; HEMISPHERIC DOMINANCE; MIDDLE AGED; NERVE CELL NETWORK; PATHOLOGY; PHYSIOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMYGDALA; CELL COUNT; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; ENTORHINAL CORTEX; FRONTAL LOBE; GYRUS CINGULI; HUMANS; MIDDLE AGED; NERVE NET; NEUROGLIA; NEURONS; PREFRONTAL CORTEX;

EID: 70350514284     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S104161020999007X     Document Type: Review

References (47)

1. Ahlbom, E., Gogvadze, V., Chen, M., Celsi, G. and Ceccatelli, S. (2000). Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death. Proceedings of the National Academy of Science, 97, 14726-14730.
2. Alexander, G. E., DeLong, M. R. and Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357-381.
3. Alexopoulos, G. S., Meyers, B. S., Young, R. C., Kakuma, T., Silbersweig, D. and Charlson, M. (1997). Clinically defined vascular depression. American Journal of Psychiatry, 154, 562-565.
4. Ali, S., Stone, M. A., Peters, J. L.,Davies, M. J. and Khunti, K. (2006). The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabetic Medicine, 23, 1165-1173.
5. Baldwin, R. C. and O'Brien, J. (2002). Vascular basis of late-onset depressive disorder. British Journal of Psychiatry, 180, 157-160.
6. Ballmaier, M. et al. (2004). Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. American Journal of Psychiatry, 161, 99-108.
7. Bonelli, R. M. and Cummings, J. L. (2007). Frontal-subcortical circuitry and behavior. Dialogues in Clinical Neuroscience, 9, 141-151.
8. Bowley, M. P., Drevets, W. C., Ongur, D. and Price, J. L. (2002). Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry, 52, 404-412.
9. Cadepond, F. et al. (2002). Steroid receptors in various glial cell lines expression and functional studies. Annals of the New York Academy of Science, 973, 484-487.
10. Cotter, D. R., Pariante, C. M. and Everall, I. P. (2001). Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Research Bulletin, 55, 585-595.
11. Cotter, D., Hudson, L. and Landau, S. (2005). Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disorders, 7, 358-369.
12. Davis, S., Thomas, A., Perry, R., Oakley, A., Kalaria, R. N. and O'Brien, J. T. (2002). Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. Journal of Neurology, Neurosurgery and Psychiatry, 73, 556-560.
13. De Groot, J. C., De Leeuw, F. E., Oudkerk, M., Hofman, A., Jolles, J. and Breteler, M. M. (2000). Cerebral white matter lesions and depressive symptoms in elderly adults. Archives of General Psychiatry, 57, 1071-1076. (Pubitemid 30818876)
14. Drevets, W. C., Price, J. L. and Furey, M. L. (2008). Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function, 213, 93-118.
15. Gittins, R. and Harrison, P. J. (2004a). Neuronal density, size and shape in the human anterior cingulate cortex: a comparison of Nissl and NeuN staining. Brain Research Bulletin, 63, 155-160.
16. Gittins, R. and Harrison, P. J. (2004b). A quantitative morphometric study of the human anterior cingulate cortex. Brain Research, 1013, 212-222.
17. Herrmann, L. L., Le Masurier, M. and Ebmeier, K. P. (2008). White matter hyperintensities in late life depression: a systematic review. Journal of Neurology Neurosurgery and Psychiatry, 79, 619-624.
18. Inazu, M., Takeda, H., Ikoshi, H., Sugisawa, M., Uchida, Y. and Matsumiya, T. (2001). Pharmacological characterization and visualization of the glial serotonin transporter. Neurochemistry International, 39, 39-49.
19. Khundakar, A. A. and Zetterstrom, T. S. (2006). Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation. Brain Research, 1106, 12-20.
20. Khundakar, A. A., Morris, C. M., Oakley, A. E., McMeekin, W. and Thomas, A. J. (2009). Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression. British Journal of Psychiatry, In press.
21. Kim, M. J., Hamilton, J. P. and Gotlib, I. H. (2008). Reduced caudate gray matter volume in women with major depressive disorder. Psychiatry Research, 164, 114-122.
22. Krishnan, M. S. et al. (2006). Relationship between periventricular and deep white matter lesions and depressive symptoms in older people: the LADIS Study. International Journal of Geriatric Psychiatry, 21, 983-989.
23. Krystal, J. H., et al. (2002). Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Molecular Psychiatry, 7 (Suppl. 1), S71-S80.
24. Laping, N. J., Teter, B., Nichols, N. R., Rozovsky, I. and Finch, C. E. (1994). Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathology, 4, 259-275.
25. McQuade, R. and Young, A. H. (2000). Future therapeutic targets in mood disorders: the glucocorticoid receptor. British Journal of Psychiatry, 177, 390-395.
26. Middleton, F. A. and Strick, P. L. (2002). Basal-ganglia "projections" to the prefrontal cortex of the primate. Cerebral Cortex, 12, 926-935.
27. Miguel-Hidalgo, J. J. et al. (2000). Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biological Psychiatry, 48, 861-873.
28. O'Brien, J. T., Ames, D., Schweitzer, I., Colman, P., Desmond, P. and Tress, B. (1996). Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. British Journal of Psychiatry, 168, 679-687.
29. Ongur, D., Drevets, W. C. and Price, J. L. (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Science of the United States of America, 95, 13290-13295.
30. Palomero-Gallagher, N., Vogt, B. A., Schleicher, A., Mayberg, H. S. and Zilles, K. (2008). Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Human Brain Mapping. E-published ahead of print, November 2008; doi: 10.1002/hbm.20667.
31. Plante, G. E. (2005). Depression and cardiovascular disease: a reciprocal relationship. Metabolism, 54, 45-48.
32. Rajkowska, G. et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry, 45, 1085-1098.
33. Rajkowska, G., Miguel-Hidalgo, J. J., Dubey, P., Stockmeier, C. A. and Krishnan, K. R. (2005). Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biological Psychiatry, 58, 297-306.
34. Sapolsky, R. M., Romero, L. M. andMunck, A.U. (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews, 21, 55-89.
35. Sheline, Y. I. et al. (2008). Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. American Journal of Psychiatry, 165, 524-532.
36. Steffens, D. C., Helms, M. J., Krishnan, K. R. and Burke, G. L. (1999). Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke, 30, 2159-2166.
37. Stockmeier, C. A. et al. (2004). Cellular changes in the postmortem hippocampus in major depression. Biological Psychiatry, 56, 640-650.
38. Taylor, W. D. et al. (2007). Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Psychological Medicine, 37, 1763-1773.
39. Teodorczuk, A. et al. (2007). White matter changes and late-life depressive symptoms: longitudinal study. British Journal of Psychiatry, 191, 212-217.
40. Thomas, A. J. et al. (2000). Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. American Journal of Psychiatry, 157, 1682-1684.
41. Thomas, A. J. et al. (2002). Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Archives of General Psychiatry, 59, 785-792.
42. Thomas, A. J., Davis, S., Morris, C., Jackson, E., Harrison, R. and O'Brien, J. T. (2005). Increase in interleukin-1beta in late-life depression. American Journal of Psychiatry, 162, 175-177.
43. Virgin, C. E., Jr. et al. (1991). Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. Journal of Neurochemistry, 57, 1422-1428.
44. Vogt, B. A., Finch,D.M. and Olson, C. R. (1992). Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cerebral Cortex, 2, 435-443.
45. West, M. J. (1999). Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends in Neuroscience, 22, 51-61.
46. Young, K. A.,Holcomb, L. A., Yazdani,U., Hicks, P. B. and German, D. C. (2004). Elevated neuron number in the limbic thalamus in major depression. American Journal of Psychiatry, 161, 1270-1277.
47. Zafra, F., Hengerer, B., Leibrock, J., Thoenen, H. and Lindholm, D. (1990). Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. European Molecular Biology Organization Journal, 9, 3545-3550.